McCormick & Schmick's ( MSSR) was among the biggest small-cap losers Tuesday in a mostly down day for the sector.

Shares plunged 23.1% after the Portland, Ore., seafood-restaurant chain sliced 5 cents off the low end of its prior third-quarter income guidance to about 16 cents a share. Same-store sales are now pegged to be flat vs. the prior forecast for a gain of between 1.5% and 2.5%, and the total-sales estimate was lowered by $2 million from the earlier low end to roughly $88 million.

Thomson Financial's estimates call for 22 cents a share, less extraordinary items, on total revenue of $90.6 million. McCormick shares lost $5.78 to $19.28.

Another small-cap name, Panacos Pharmaceuticals ( PANC), slid 21% on news chief financial officer Peyton Marshall had resigned. VP Robert Pelletier will replace him in the interim. Shares of the Watertown, Mass., biotech company were off 53 cents at $1.99.

And Standard Pacific ( SPF) sank 10.6% after UBS began coverage on the Irvine, Calif., homebuilder with a sell rating. The move comes a day after the company priced a $100 million convertible-senior-bond offering and eliminated its 4-cent quarterly dividend.

Standard Pacific shares shed 75 cents to $6.30. That helped pressure the Russell 2000, which also harbors McCormick, as well as the S&P SmallCap 600. Both trackers were lately losing around 0.4%.

Strongly on the upside, however, was HandHeld Entertainment ( ZVUE). Shares catapulted 23.4% after the San Francisco-based outfit said it has filled an "initial" order for 10,000 of its Zvue 250 MP3 video players -- the largest in its history, according to the company. The products will become part of a rewards program for a "major" U.S. credit-card company, said HandHeld. Shares were trading at $2.95.

Similarly, California's Centillium Communications ( CTLM) soared 15.8% to $1.76 after scoring a multimillion-dollar order for one of its Mustang system-on-chip processor from a "leading" Japanese networking-equipment maker. The products are slated for delivery within the next six months and will ultimately "power the high-bandwidth broadband access and next-generation network services in optical fiber-to-the-premises networks for hundreds of thousands of subscriber lines," said Centillium.

Oppenheimer stamped a buy rating on AspenBio Pharma ( APPY), saying that its proposed appendicitis diagnostic-test product is promising, seems to be unique and makes the biotech company an attractive takeout candidate. Shares of the Colorado-based company leapt $1.08, or 15.7%, to $7.95.

Elsewhere in the green, Akeena Solar ( AKNS) jumped on word Suntech Power ( STP) had signed a letter of intent to make 10 to 14 megawatts worth of Akeena's Andalay solar panels in 2008. Shares of California-based Akeena ramped up 11.5% to $8.14. Suntech recently lost 1.5%.

If you liked this article you might like

Lackluster Finish for U.S. Stocks

Lackluster Finish for U.S. Stocks

Stocks Continue to Waver at the Flat Line

Stocks Continue to Waver at the Flat Line

Oil Slides as Stocks Post a Mixed Showing

Oil Slides as Stocks Post a Mixed Showing

Stocks Flutter Near the Flat Line

Stocks Flutter Near the Flat Line

Wall Street Falls Amid Inflation Talk

Wall Street Falls Amid Inflation Talk